UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
British journal of psychiatry, ISSN 0007-1250, 10/2011, Volume 199, Issue 4, pp. 271 - 271
Journal Article
The Annals of pharmacotherapy, ISSN 1060-0280, 11/2011, Volume 45, Issue 11, pp. 1416 - 1424
Journal Article
Biology of reproduction, ISSN 0006-3363, 11/2003, Volume 69, Issue 5, pp. 1665 - 1674
Journal Article
International Journal of Obesity, ISSN 0307-0565, 03/2005, Volume 29, Issue 1, pp. S17 - S23
Journal Article
European journal of medicinal chemistry, ISSN 0223-5234, 01/2019, Volume 162, pp. 650 - 665
Rosiglitazone | Type 2 diabetes mellitus | Glucose intolerance | Nitric oxide | Ferulic acid | Nitric Oxide Donors - chemistry | Rosiglitazone - pharmacology | Coumaric Acids - chemistry | Anti-Inflammatory Agents | Humans | Cells, Cultured | Rosiglitazone - chemistry | Kidney Tubules, Collecting - cytology | Metabolic Syndrome - drug therapy | Antioxidants | Aquaporin 2 - metabolism | Glucose Intolerance - drug therapy | Kidney Tubules, Collecting - metabolism | Drug Design | Nitric Oxide Donors - therapeutic use | Nitric Oxide Donors - pharmacology | Rosiglitazone - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Microsomes, Liver | Coumaric Acids - pharmacology | Coumaric Acids - therapeutic use | Type 2 diabetes | Glucose metabolism | Liver | Analysis | Aquaporins | Hypoglycemic agents | Glucose | Drug discovery | Dextrose | Index Medicus
Journal Article
BMJ, ISSN 0959-8138, 2010, Volume 341, Issue sep29 2, pp. c5279 - c5279
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 24, pp. 2247 - 2256
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Body Mass Index | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Life Style | Metformin - therapeutic use | Follow-Up Studies | Glycated Hemoglobin A - metabolism | Humans | Male | Thiazolidinediones - adverse effects | Metformin - adverse effects | Diabetes Mellitus, Type 2 - blood | Thiazolidinediones - therapeutic use | Weight Loss | Treatment Failure | Adolescent | Diabetes Mellitus, Type 2 - therapy | Survival Analysis | Female | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Child | Hypoglycemic Agents - adverse effects | Measurement | Type 2 diabetes | Patient outcomes | Glycemic index | Dosage and administration | Metformin | Rosiglitazone maleate | Drug therapy | Diabetes mellitus | Hemoglobin | Rosiglitazone | Clinical trials | Lifestyles | Teenagers | Diabetes | Children | Adolescents | Diabetes mellitus (non-insulin dependent) | Insulin | Index Medicus | Abridged Index Medicus
Journal Article
Life sciences (1973), ISSN 0024-3205, 03/2021, Volume 269, pp. 119013 - 119013
Rosiglitazone | Diabetic retinopathy | Semaglutide | Combination therapy | Rodent animals | Diabetic Retinopathy - drug therapy | Inflammation - pathology | Rosiglitazone - pharmacology | TOR Serine-Threonine Kinases - metabolism | Antioxidants - metabolism | Humans | Ependymoglial Cells - metabolism | Male | Phosphatidylinositol 3-Kinases - metabolism | Protective Agents - therapeutic use | Glial Fibrillary Acidic Protein - metabolism | Glucagon-Like Peptides - pharmacology | Protective Agents - pharmacology | Rosiglitazone - therapeutic use | Drug Therapy, Combination | Ependymoglial Cells - pathology | Proto-Oncogene Proteins c-akt - metabolism | Disease Models, Animal | Cell Line | Cell Survival - drug effects | Ependymoglial Cells - drug effects | Rats, Sprague-Dawley | Animals | Signal Transduction - drug effects | Glucagon-Like Peptides - therapeutic use | Antioxidants | Analysis | Hypoglycemic agents | Ophthalmology | Glucose | Dextrose | Index Medicus
Journal Article
Diabetes care, ISSN 0149-5992, 01/2020, Volume 43, Issue 1, pp. 187 - 195
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Life Style | Follow-Up Studies | Humans | Male | Pediatric Obesity - therapy | Diabetic Nephropathies - blood | Diabetic Nephropathies - therapy | Metformin - adverse effects | Rosiglitazone - adverse effects | Rosiglitazone - administration & dosage | Hypoglycemic Agents - administration & dosage | Diabetes Mellitus, Type 2 - therapy | Weight Reduction Programs - methods | Female | Metformin - administration & dosage | Drug Therapy, Combination | Child | Obesity, Morbid - therapy | Diabetes Mellitus, Type 2 - complications | Bariatric Surgery | Glomerular Filtration Rate | Pediatric Obesity - blood | Treatment Outcome | Obesity, Morbid - complications | Diabetic Nephropathies - complications | Diabetes Mellitus, Type 2 - blood | Adolescent | Pediatric Obesity - complications | Blood Glucose - metabolism | Hypoglycemic Agents - adverse effects | Obesity, Morbid - blood | Type 2 diabetes | Complications and side effects | Overweight persons | Obesity | Care and treatment | Patient outcomes | Surgery | Diabetic nephropathies | Hypoglycemic agents | Therapy | Health services | Albumins | Teenagers | Secondary analysis | Adolescents | Hyperfiltration | Diabetes mellitus (non-insulin dependent) | Age | Medical research | Glucose monitoring | Kidneys | Epidermal growth factor receptors | Medical treatment | Diabetes mellitus | Insulin | Glomerular filtration rate | Rosiglitazone | Research design | Diabetes | Metformin | Kidney diseases | Gastrointestinal surgery | Age composition | Index Medicus | 0105 | Pathophysiology | Complications
Journal Article
Oncotarget, ISSN 1949-2553, 12/2018, Volume 9, Issue 102, pp. 37614 - 37615
Journal Article
International Journal of Obesity, ISSN 0307-0565, 03/2019, Volume 43, Issue 3, pp. 567 - 580
Endocrinology & Metabolism | Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Rosiglitazone - pharmacology | Liver - metabolism | Mice, Inbred C57BL | ARNTL Transcription Factors - metabolism | Male | Muscle, Skeletal - metabolism | Insulin - blood | Hypoglycemic Agents - pharmacology | Blood Glucose - drug effects | Adipose Tissue - metabolism | Animals | Liver - drug effects | Diet, High-Fat | Muscle, Skeletal - drug effects | Mice | Adipose Tissue - drug effects | Circadian rhythms | Obesity | Transcription factors | Genetic aspects | Rosiglitazone maleate | Drug therapy | Health aspects | Ketogenic diet | Testing | Sensitivity analysis | Adipose tissue | Liver | Diabetes mellitus | Muscles | Genomes | Insulin | High fat diet | Recruitment | Sensitivity | Diet | Animal tissues | BMAL1 protein | Rosiglitazone | Insulin resistance | Localization | Index Medicus
Journal Article
Reproductive biology and endocrinology, 10/2018, Volume 16, Issue 1
Journal Article
ACS nano, ISSN 1936-0851, 09/2017, Volume 11, Issue 9, pp. 9223 - 9230
adipose tissue | browning agent | microneedle patch | drug delivery | obesity | Physical Sciences | Chemistry | Materials Science | Nanoscience & Nanotechnology | Technology | Materials Science, Multidisciplinary | Science & Technology - Other Topics | Chemistry, Multidisciplinary | Chemistry, Physical | Science & Technology | Hypoglycemic Agents - therapeutic use | Transdermal Patch | Anti-Obesity Agents - administration & dosage | Drug Delivery Systems - instrumentation | Obesity - drug therapy | Mice, Inbred C57BL | Male | Anti-Obesity Agents - therapeutic use | Rosiglitazone - administration & dosage | Adipocytes, White - drug effects | Animals | Hypoglycemic Agents - administration & dosage | Rosiglitazone - therapeutic use | Adipose Tissue, White - drug effects | Index Medicus
Journal Article
Biomedicine & pharmacotherapy, ISSN 0753-3322, 12/2020, Volume 132, pp. 110741 - 110741
Rosiglitazone | Capsaicin | Pioglitazone | Troglitazone | Glioblastoma | Apoptosis | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Rosiglitazone - pharmacology | Apoptosis - drug effects | Capsaicin - pharmacology | Humans | Brain Neoplasms - pathology | Pioglitazone - pharmacology | Brain Neoplasms - drug therapy | PPAR gamma - metabolism | Capsaicin - administration & dosage | Dose-Response Relationship, Drug | Drug Synergism | Up-Regulation - drug effects | TRPV Cation Channels - metabolism | Rosiglitazone - administration & dosage | Pioglitazone - administration & dosage | Glioblastoma - pathology | Cell Line, Tumor | Ligands | Glioblastoma - drug therapy | Phenols | Glioblastoma multiforme | Index Medicus
Journal Article